Study of Clinical Course of Newly Diagnosed Moderate to Severe Ulcerative Colitis in Korea
Last updated on July 2021Recruitment
- Recruitment Status
- Active, not recruiting
- Estimated Enrollment
- 400
Summary
- Conditions
- Colitis Ulcerative
- Type
- Observational
- Design
- Observational Model: CohortTime Perspective: Prospective
Participation Requirements
- Age
- Between 7 years and 125 years
- Gender
- Both males and females
Description
This is a multicenter (when medical research study takes place in more than one country), prospective (study following participants forward in time), disease-oriented and hospital-based 5-year follow-up longitudinal study in Korean participants with newly diagnosed moderate to severe ulcerative coli...
This is a multicenter (when medical research study takes place in more than one country), prospective (study following participants forward in time), disease-oriented and hospital-based 5-year follow-up longitudinal study in Korean participants with newly diagnosed moderate to severe ulcerative colitis who visit tertiary referral hospital. As the study is observational in nature, no intervention will be received by participants. Efficacy will primarily be assessed by number of relapses and percentage of participants achieving sustained remission (clinical, endoscopic and combined remission).
Tracking Information
- NCT #
- NCT02229344
- Collaborators
- Not Provided
- Investigators
- Study Director: Janssen Korea, Ltd., Korea Clinical Trial Janssen Korea, Ltd., Korea